✦ LIBER ✦

SAFETY AND EFFICACY OF LONG ACTING RISPERIDONE IN PATIENTS SWITCHED OVER FROM TYPICAL DEPOT OR ANTIPSYCHOTICS

✍ Scribed by Swapna Verma

Book ID: 119557645
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 60 KB
Volume: 102
Category: Article
ISSN: 0920-9964
DOI: 10.1016/s0920-9964(08)70827-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-acting injectable risperidone: Safe

Long-acting injectable risperidone: Safety and efficacy in patients switched from conventional depot antipsychotics

✍ M. Turner; M. Eerdekens; M. Jacko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Switching stable patients with schizophr

Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: reasons for switching and safety

✍ Chris Hawley; Martin Turner; Muhammud A Latif; Vivienne Curtis; Packeruther T Sa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB 👁 2 views

## Abstract ## Objective An international, non‐randomised study evaluated efficacy and safety of risperidone long‐acting injectable (RLAI) compared to previous treatment. To investigate generisability of the European data set to the UK subset safety and switching data are reported here. ## Method

P.3.a.008 Efficacy and safety of long-ac

P.3.a.008 Efficacy and safety of long-acting risperidone injection after switching from antipsychotics in Chinese patients

✍ H.F. Li; N.F. Gu; M. Zhou; F.J. Jia; Z.H. Zhao; J.X. Fan; G. Wang; X.L. Sun; M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 67 KB

P.2.013 Safety and efficacy of long-acti

P.2.013 Safety and efficacy of long-acting risperidone in schizophrenia: A 12-week, open-label study in stable patients switched from typical and atypical oral antipsychotics

✍ M. Cetin; S. Ebrinc; C. Basoglu; U.B. Semiz; H. Gunay; M.S. Iyisoy; B.M. Ergun; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 206 KB

Switching stable patients with schizophr

Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome

✍ Keith Lloyd; Muhammud A. Latif; Steve Simpson; Keshar L. Shrestha 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 2 views

## Abstract ## Objective This international, non‐randomised study evaluated maintained efficacy and safety of Risperidone Long‐Acting Injectable (RLAI) compared to previous medications. To investigate the possible effect of differences in national health care systems across Europe, the UK subset e

Long-term safety and efficacy of long-ac

Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients

✍ Werner Kissling; Per Glue; Rossella Medori; Steve Simpson 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Abstract This subgroup analysis of the 6‐month, open‐label Switch to Risperidone Microspheres (StoRMi) trial evaluated long‐term safety and efficacy of a direct conversion to risperidone long‐acting injectable (RLAI) in 52 elderly patients (≥65 years) with psychosis stabilized on oral or depot a